X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-01-16 | PDEX | Pro Dex Inc | Cabillot Raymond E | Dir, 10% | S - Sale | $44.75 | -8,313 | 344,683 | -2% | -$371,988 | |||||
2025-01-16 | ANGO | Angiodynamics Inc | Nighan Warren Jr | SVP Quality, Regulatory | S - Sale | $12.31 | -4,060 | 41,817 | -9% | -$49,979 | ||||||
2025-01-17 | SSII | Ss Innovations International, Inc. | Srivastava Sudhir | COB, CEO, 10% | S - Sale | $1.37 | -364,431 | 97,730,668 | 0% | -$499,999 | ||||||
| M | 2025-01-14 | PDEX | Pro Dex Inc | Cabillot Raymond E | Dir, 10% | S - Sale | $45.18 | -3,026 | 352,996 | -1% | -$136,715 | |||||
2025-01-11 | NVCR | Novocure Ltd | Paravasthu Mukund | COO | S - Sale | $26.81 | -2,160 | 31,437 | -6% | -$57,906 | ||||||
2025-01-14 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.74 | +11,547 | 15,809,351 | 0% | +$8,522 | ||||||
| M | 2025-01-10 | PDEX | Pro Dex Inc | Cabillot Raymond E | Dir, 10% | S - Sale | $46.93 | -4,824 | 356,022 | -1% | -$226,408 | |||||
2025-01-13 | BVS | Bioventus Inc. | Claypoole Robert E | Pres, CEO | S - Sale | $9.10 | -28,786 | 64,964 | -31% | -$261,953 | ||||||
| M | 2025-01-10 | ATEC | Alphatec Holdings, Inc. | Sponsel David | EVP, Sales | S - Sale | $10.71 | -58,521 | 502,311 | -10% | -$626,591 | |||||
| M | 2025-01-10 | OFIX | Orthofix Medical Inc. | Calafiore Massimo | Pres, CEO | S - Sale | $16.98 | -19,281 | 124,151 | -13% | -$327,376 | |||||
| M | 2025-01-10 | OFIX | Orthofix Medical Inc. | Gillespie Geoffrey C | CAO | S - Sale | $16.98 | -475 | 40,090 | -1% | -$8,065 | |||||
| D | 2025-01-10 | GMED | Globus Medical Inc | Pfeil Keith W | COO, CFO | S - Sale+OE | $88.29 | -14,167 | 0 | -100% | -$1,250,770 | |||||
2025-01-10 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.73 | +18,226 | 15,797,804 | 0% | +$13,281 | ||||||
2025-01-08 | RMD | Resmed Inc | Sandercock Brett | CFO | S - Sale | $234.04 | -1,000 | 92,864 | -1% | -$234,040 | ||||||
| M | 2025-01-07 | OFIX | Orthofix Medical Inc. | Gillespie Geoffrey C | CAO | S - Sale | $17.05 | -476 | 40,565 | -1% | -$8,117 | |||||
2025-01-09 | SSII | Ss Innovations International, Inc. | Moll Frederic H | Dir | P - Purchase | $1.37 | +1,457,726 | 1,457,726 | New | +$2,000,000 | ||||||
2025-01-09 | SSII | Ss Innovations International, Inc. | Srivastava Sudhir | COB, CEO, 10% | S - Sale | $1.37 | -1,457,726 | 98,095,099 | -1% | -$2,000,000 | ||||||
2025-01-07 | INSP | Inspire Medical Systems, Inc. | Rondoni John | CTO | S - Sale | $215.00 | -58 | 11,322 | -1% | -$12,470 | ||||||
| D | 2025-01-07 | BDX | Becton Dickinson & Co | Neal Shana Carol | EVP, Chief People Officer | S - Sale+OE | $235.00 | -788 | 16,201 | -5% | -$185,180 | |||||
2025-01-08 | SGHT | Sight Sciences, Inc. | Hayden Jeremy B. | GC | S - Sale | $3.26 | -1,810 | 152,013 | -1% | -$5,899 | ||||||
2025-01-08 | SGHT | Sight Sciences, Inc. | Badawi David | CTO | S - Sale | $3.26 | -3,829 | 1,749,541 | 0% | -$12,479 | ||||||
2025-01-06 | NARI | Inari Medical, Inc. | Hoffman William | Dir | S - Sale | $60.47 | -200,000 | 238,987 | -46% | -$12,093,175 | ||||||
2025-01-07 | NXGL | Nexgel, Inc. | Henry Scott Robert | Dir | S - Sale | $3.37 | -3,000 | 141,553 | -2% | -$10,097 | ||||||
2025-01-06 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.78 | +18,411 | 15,779,578 | 0% | +$14,270 | ||||||
2025-01-03 | SGHT | Sight Sciences, Inc. | Badawi David | CTO | S - Sale | $3.52 | -3,111 | 1,753,370 | 0% | -$10,957 | ||||||
2025-01-03 | SGHT | Sight Sciences, Inc. | Hayden Jeremy B. | GC | S - Sale | $3.52 | -4,864 | 153,823 | -3% | -$17,131 | ||||||
2025-01-03 | SGHT | Sight Sciences, Inc. | Bauerlein Alison | CFO | S - Sale | $3.52 | -10,102 | 382,453 | -3% | -$35,579 | ||||||
2025-01-02 | SGHT | Sight Sciences, Inc. | Badawi Paul | Pres, CEO | S - Sale | $3.60 | -12,236 | 5,713,197 | 0% | -$44,013 | ||||||
2025-01-03 | PEN | Penumbra Inc | Grewal Harpreet | Dir | S - Sale | $241.28 | -167 | 8,530 | -2% | -$40,294 | ||||||
2025-01-02 | PEN | Penumbra Inc | Kassing Don W. | Dir | S - Sale | $238.84 | -170 | 9,165 | -2% | -$40,603 | ||||||
2025-01-02 | SIBN | Si-Bone, Inc. | Recupero Anthony J | Pres, Commercial Ops | S - Sale | $13.90 | -3,670 | 222,814 | -2% | -$51,014 | ||||||
2025-01-02 | SIBN | Si-Bone, Inc. | Maheshwari Anshul | CFO | S - Sale | $13.91 | -5,304 | 189,319 | -3% | -$73,802 | ||||||
| D | 2025-01-02 | NXGL | Nexgel, Inc. | Levy Adam R. | CEO | S - Sale+OE | $3.96 | -4,000 | 768,568 | -1% | -$15,828 | |||||
2024-12-31 | SSII | Ss Innovations International, Inc. | Srivastava Sudhir | COB, CEO, 10% | S - Sale | $1.37 | -3,644,315 | 99,552,825 | -4% | -$5,000,000 | ||||||
2024-12-31 | SSII | Ss Innovations International, Inc. | Moll Frederic H | Dir | P - Purchase | $1.37 | +2,186,589 | 6,415,589 | +52% | +$3,000,000 | ||||||
2025-01-02 | RMD | Resmed Inc | Farrell Peter C | Dir | S - Sale | $230.99 | -2,000 | 79,218 | -2% | -$461,980 | ||||||
2025-01-02 | RMD | Resmed Inc | Rider Michael J | Global GC | S - Sale | $230.99 | -75 | 9,038 | -1% | -$17,324 | ||||||
| DM | 2025-01-02 | BSX | Boston Scientific Corp | Sorenson John Bradley | EVP, Global Operations | S - Sale+OE | $89.96 | -6,461 | 32,977 | -16% | -$581,241 | |||||
| D | 2025-01-03 | BSX | Boston Scientific Corp | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | S - Sale+OE | $89.86 | -7,152 | 28,454 | -20% | -$642,658 | |||||
| D | 2025-01-03 | BSX | Boston Scientific Corp | Brennan Daniel J. | EVP, CFO | S - Sale+OE | $89.86 | -9,689 | 223,921 | -4% | -$870,636 | |||||
2025-01-02 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.68 | +5,302 | 15,761,167 | 0% | +$3,616 | ||||||
2024-12-31 | NVNO | Envveno Medical Corp | Duhay Francis | Dir | P - Purchase | $3.07 | +81,433 | 102,344 | +389% | +$249,999 | ||||||
| D | 2025-01-02 | ICUI | Icu Medical Inc/de | Jain Vivek | COB, CEO | S - Sale+OE | $155.48 | -1,373 | 193,291 | -1% | -$213,474 | |||||
2024-12-13 | CERS | Cerus Corp | Gregory Dean A. | Dir | P - Purchase | $1.70 | +1,725 | 61,725 | +3% | +$2,933 | ||||||
2024-12-31 | NVNO | Envveno Medical Corp | Gray Robert | Dir | P - Purchase | $2.94 | +3,500 | 11,155 | +46% | +$10,290 | ||||||
2024-12-31 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.68 | +443 | 15,755,865 | 0% | +$300 | ||||||
2024-12-24 | HRGN | Harvard Apparatus Regenerative Technology, Inc. | He Junli | CEO | P - Purchase | $2.87 | +2,299 | 262,000 | +1% | +$6,598 | ||||||
| M | 2024-12-26 | SSII | Ss Innovations International, Inc. | Cohen Barry F | COO - Americas | P - Purchase | $8.11 | +629 | 8,960,729 | 0% | +$5,102 | |||||
2024-12-27 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.62 | +542 | 15,755,422 | 0% | +$337 | ||||||
2024-12-23 | OBIO | Orchestra Biomed Holdings, Inc. | Hochman David P | See Remarks | P - Purchase | $4.66 | +4,000 | 923,640 | 0% | +$18,640 | ||||||
2024-12-23 | BVS | Bioventus Inc. | Singleton Mark Leonard | SVP, CFO | S - Sale | $10.53 | -10,733 | 105,162 | -9% | -$113,018 | ||||||
2024-12-23 | BVS | Bioventus Inc. | Church Katrina J | SVP, Chief Compliance Officer | S - Sale | $10.53 | -2,535 | 47,264 | -5% | -$26,694 | ||||||
2024-12-23 | BVS | Bioventus Inc. | D'Adamio Anthony | SVP, GC | S - Sale | $10.53 | -5,848 | 109,578 | -5% | -$61,579 | ||||||
2024-12-24 | NVNO | Envveno Medical Corp | Shrivastava Sanjay | Dir | P - Purchase | $2.90 | +5,400 | 9,288 | +139% | +$15,660 | ||||||
2024-12-23 | SSII | Ss Innovations International, Inc. | Srivastava Sudhir | COB, CEO, 10% | S - Sale | $1.37 | -3,645,224 | 103,207,140 | -3% | -$5,001,247 | ||||||
| D | 2024-12-20 | GKOS | Glaukos Corp | Gilliam Joseph E | Pres, COO | S - Sale+OE | $149.85 | -3,328 | 102,169 | -3% | -$498,716 | |||||
| D | 2024-12-20 | GKOS | Glaukos Corp | Kliman Gilbert H | Dir | S - Sale+OE | $150.28 | -10,000 | 32,336 | -24% | -$1,502,800 | |||||
2024-12-20 | PEN | Penumbra Inc | Elsesser Adam | CEO, Pres | S - Sale | $242.96 | -15,000 | 842,582 | -2% | -$3,644,438 | ||||||
2024-12-20 | NXGL | Nexgel, Inc. | Henry Scott Robert | Dir | S - Sale | $4.64 | -3,000 | 144,553 | -2% | -$13,935 | ||||||
| M | 2024-12-19 | SSII | Ss Innovations International, Inc. | Cohen Barry F | COO - Americas | P - Purchase | $5.28 | +719 | 8,960,100 | 0% | +$3,797 | |||||
2024-12-19 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.62 | +2,518 | 15,754,880 | 0% | +$1,550 | ||||||
2024-12-19 | NVNO | Envveno Medical Corp | Jenusaitis Matthew | Dir | P - Purchase | $2.53 | +9,620 | 16,545 | +139% | +$24,339 | ||||||
2024-12-20 | NARI | Inari Medical, Inc. | Hykes Andrew | Pres, CEO | S - Sale | $55.29 | -3,000 | 444,960 | -1% | -$165,870 | ||||||
2024-12-11 | PLSE | Pulse Biosciences, Inc. | Barrett Burke Thomas | Former President and CEO | S - Sale | $17.42 | -50,000 | 63,172 | -44% | -$871,000 | ||||||
2024-12-19 | BDX | Becton Dickinson & Co | Garrison Michael David | EVP, Pres, Medical | S - Sale | $223.33 | -2,838 | 6,141 | -32% | -$633,811 | ||||||
2024-12-19 | OBIO | Orchestra Biomed Holdings, Inc. | Taylor Andrew Lawrence | CFO | P - Purchase | $4.83 | +1,000 | 344,960 | 0% | +$4,830 | ||||||
2024-12-19 | NVNO | Envveno Medical Corp | Berman Robert Andrew | CEO | P - Purchase | $2.55 | +12,000 | 222,236 | +6% | +$30,600 | ||||||
2024-10-05 | TLSI | Trisalus Life Sciences, Inc. | Cox Bryan F. | Chief Scientific, Manufact. | S - Sale | $4.44 | -314 | 86,382 | 0% | -$1,394 | ||||||
2024-12-17 | TLSI | Trisalus Life Sciences, Inc. | Frankenius Equity Ab | 10% | P - Purchase | $3.97 | +62,972 | 6,230,748 | +1% | +$249,999 | ||||||
2024-12-17 | OFIX | Orthofix Medical Inc. | Gillespie Geoffrey C | CAO | S - Sale | $17.84 | -26 | 41,041 | 0% | -$464 | ||||||
| M | 2024-12-17 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.60 | +29,708 | 15,752,362 | 0% | +$17,928 | |||||
2024-12-18 | OBIO | Orchestra Biomed Holdings, Inc. | Hochman David P | See Remarks | P - Purchase | $4.91 | +5,000 | 919,640 | +1% | +$24,550 | ||||||
2024-12-16 | NARI | Inari Medical, Inc. | Hoffman William | Dir | S - Sale | $55.66 | -60,000 | 441,233 | -12% | -$3,339,704 | ||||||
2024-12-13 | PLSE | Pulse Biosciences, Inc. | Duggan Robert W | Dir, 10% | P - Purchase | $17.18 | +55,256 | 43,290,683 | 0% | +$949,298 | ||||||
2024-12-16 | DXCM | Dexcom Inc | Stern Sadie | EVP, CHRO | S - Sale | $76.87 | -424 | 70,768 | -1% | -$32,593 | ||||||
2024-12-16 | DXCM | Dexcom Inc | Sylvain Jereme M | EVP, Chief Financal Officer | S - Sale | $76.87 | -744 | 80,030 | -1% | -$57,191 | ||||||
2024-12-16 | DXCM | Dexcom Inc | Leach Jacob Steven | EVP, COO | S - Sale | $76.87 | -744 | 311,467 | 0% | -$57,191 | ||||||
2024-12-16 | DXCM | Dexcom Inc | Heller Bridgette P | Dir | S - Sale | $76.87 | -1,000 | 23,349 | -4% | -$76,870 | ||||||
2024-12-16 | PODD | Insulet Corp | Benjamin Eric | EVP, CPXPO | S - Sale | $267.60 | -4,362 | 18,702 | -19% | -$1,167,271 | ||||||
2024-12-12 | PLES | Pulse Biosciences, Inc. | Duggan Robert W | Dir, 10% | P - Purchase | $17.13 | +45,404 | 43,235,427 | 0% | +$777,771 | ||||||
2024-12-12 | CERS | Cerus Corp | Bjerkholt Eric | Dir | S - Sale | $1.79 | -20,000 | 162,133 | -11% | -$35,700 | ||||||
2024-12-16 | CERS | Cerus Corp | Jensen Chrystal | GC | S - Sale | $1.71 | -16,667 | 457,578 | -4% | -$28,501 | ||||||
2024-12-13 | CTSO | Cytosorbents Corp | Mariani Peter J | CFO | P - Purchase | $0.96 | +20,000 | 401,363 | +5% | +$19,294 | ||||||
| D | 2024-12-11 | GKOS | Glaukos Corp | Kliman Gilbert H | Dir | S - Sale+OE | $144.01 | -2,000 | 32,336 | -6% | -$288,020 | |||||
2024-12-11 | PLSE | Pulse Biosciences, Inc. | Duggan Robert W | Dir, 10% | P - Purchase | $17.35 | +56,054 | 43,190,023 | 0% | +$972,344 | ||||||
2024-12-11 | ATEC | Alphatec Holdings, Inc. | Sponsel David | EVP, Sales | S - Sale | $9.69 | -62,018 | 560,832 | -10% | -$600,954 | ||||||
| M | 2024-12-11 | CTSO | Cytosorbents Corp | Mariani Peter J | CFO | P - Purchase | $0.89 | +31,363 | 381,363 | +9% | +$27,975 | |||||
2024-12-10 | TLSI | Trisalus Life Sciences, Inc. | Desai Arjun Jj | Dir | S - Sale | $3.69 | -30,000 | 247,127 | -11% | -$110,700 | ||||||
2024-12-10 | NARI | Inari Medical, Inc. | Tu Thomas | Chief Medical Officer | S - Sale | $55.00 | -4,000 | 304,036 | -1% | -$220,000 | ||||||
2024-12-11 | AORT | Artivion, Inc. | Holloway Jean F | SVP, GC | S - Sale | $30.13 | -8,070 | 153,862 | -5% | -$243,109 | ||||||
2024-12-10 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.62 | +9,167 | 15,722,654 | 0% | +$5,728 | ||||||
2024-12-10 | SSII | Ss Innovations International, Inc. | Srivastava Sudhir | COB, CEO, 10% | S - Sale | $1.46 | -1,400,620 | 106,852,364 | -1% | -$2,049,107 | ||||||
2024-12-10 | SSII | Ss Innovations International, Inc. | Adams Timothy P. | Dir | P - Purchase | $1.46 | +1,400,620 | 3,781,902 | +59% | +$2,049,107 | ||||||
2024-12-10 | PODD | Insulet Corp | Budden Lauren | Group VP, CAO, Controller | S - Sale | $275.62 | -915 | 5,733 | -14% | -$252,192 | ||||||
2024-12-09 | RMD | Resmed Inc | Sandercock Brett | CFO | S - Sale | $244.23 | -1,000 | 93,864 | -1% | -$244,230 | ||||||
| DM | 2024-12-06 | BDX | Becton Dickinson & Co | Goette Roland | EVP, Pres, EMEA | S - Sale+OE | $220.76 | -5,121 | 15,516 | -25% | -$1,130,529 | |||||
2024-12-06 | BDX | Becton Dickinson & Co | Neal Shana Carol | EVP, Chief People Officer | S - Sale | $220.49 | -1,000 | 16,989 | -6% | -$220,490 | ||||||
| M | 2024-12-06 | FNA | Paragon 28, Inc. | Mvm Partners, LLC | 10% | S - Sale | $10.06 | -39,888 | 10,386,145 | 0% | -$401,384 | |||||
2024-12-06 | FNA | Paragon 28, Inc. | Wright Kristina | Dir | S - Sale | $10.00 | -2,360 | 32,118 | -7% | -$23,602 | ||||||
| A | 2024-12-06 | AORT | Artivion, Inc. | Horton Amy | VP, Chief Accounting Officer | S - Sale | $29.05 | -4,425 | 135,564 | -3% | -$128,552 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |